What is the Market's View on Twist Bioscience Corp (TWST) Stock's Price and Volume Trends Thursday?

Twist Bioscience Corp (TWST) stock has fallen 4.33% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Twist Bioscience Corp has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TWST!

See Full TWST Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With TWST Stock Today?

Twist Bioscience Corp (TWST) stock is down -1.29% while the S&P 500 has gained 0.9% as of 11:24 AM on Thursday, Mar 7. TWST is lower by -$0.49 from the previous closing price of $38.08 on volume of 118,714 shares. Over the past year the S&P 500 is up 29.20% while TWST has gained 103.08%. TWST lost -$3.60 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Twist Bioscience Corp click here.

More About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States. Click Here to get the full Stock Report for Twist Bioscience Corp stock.